PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

A novel therapy, using Ghrelin with pegylated G-CSF, inhibits brain hemorrhage from ionizing radiation or combined radiation injury.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 34368440 ↗2019Reported benefit

A novel therapy, using Ghrelin with pegylated G-CSF, inhibits brain hemorrhage from ionizing radiation or combined radiation injury.

MouseRadiationB6D2F1/JFemaleSubcutaneous for both, in 0.2 mLGhrelin 113 micrograms/kg; pegylated G-CSF 1000 micrograms/…First doses 24 h after irradiation or combined injury

Model: 9.5 Gy whole-body cobalt-60 gamma irradiation alone, or followed within 1 h by a 15% total body surface area skin wound

Ghrelin with pegylated G-CSF reduced brain haemorrhage after radiation and combined injury, restored platelet counts, ghrelin receptors, ATP and phospho-AKT, and lowered active caspase-3.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.